Trademark: 88681679
Status Date
Wednesday, November 22, 2023
Filing Date
Wednesday, November 6, 2019
Published for Opposition
Tuesday, April 6, 2021
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, including T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
Nov 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 22, 2023
Sou Extension 5 Granted
Nov 21, 2023
Sou Extension 5 Filed
Nov 21, 2023
Sou Teas Extension Received
Aug 2, 2023
Teas Change Of Correspondence Received
Aug 2, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Change Of Owner Address Received
Jun 1, 2023
Notice Of Approval Of Extension Request E-Mailed
May 30, 2023
Sou Extension 4 Granted
May 30, 2023
Sou Extension 4 Filed
May 30, 2023
Sou Teas Extension Received
Nov 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 28, 2022
Sou Extension 3 Granted
Nov 28, 2022
Sou Extension 3 Filed
Nov 28, 2022
Sou Teas Extension Received
May 26, 2022
Notice Of Approval Of Extension Request E-Mailed
May 24, 2022
Sou Extension 2 Granted
May 24, 2022
Sou Extension 2 Filed
May 24, 2022
Sou Teas Extension Received
Feb 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 18, 2022
Sou Extension 1 Granted
Dec 1, 2021
Sou Extension 1 Filed
Feb 8, 2022
Case Assigned To Intent To Use Paralegal
Jan 5, 2022
Notice Of Revival - E-Mailed
Jan 5, 2022
Sou Extension Received With Teas Petition
Jan 5, 2022
Petition To Revive-Granted
Jan 5, 2022
Teas Petition To Revive Received
Jan 3, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 3, 2022
Abandonment - No Use Statement Filed
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Mar 1, 2021
Approved For Pub - Principal Register
Mar 1, 2021
Teas/Email Correspondence Entered
Feb 26, 2021
Correspondence Received In Law Office
Feb 26, 2021
Teas Response To Office Action Received
Sep 1, 2020
Notification Of Non-Final Action E-Mailed
Sep 1, 2020
Non-Final Action E-Mailed
Sep 1, 2020
Non-Final Action Written
Aug 5, 2020
Teas/Email Correspondence Entered
Aug 5, 2020
Correspondence Received In Law Office
Aug 5, 2020
Teas Response To Office Action Received
Feb 5, 2020
Notification Of Non-Final Action E-Mailed
Feb 5, 2020
Non-Final Action E-Mailed
Feb 5, 2020
Non-Final Action Written
Jan 29, 2020
Assigned To Examiner
Nov 13, 2019
New Application Office Supplied Data Entered
Nov 9, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
